Comparison of the prognostic significance of 5 comorbidity scores and 12 functional tests in a prospective multiple myeloma patient cohort-Reference-Cited by-同舟云学术

Comparison of the prognostic significance of 5 comorbidity scores and 12 functional tests in a prospective multiple myeloma patient cohort

Published:2021-06 Issue:18 Volume:127 Page:3422-3436
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Scheubeck Sophia¹²^ORCID,Ihorst Gabriele³,Schoeller Katja¹²,Holler Maximilian¹²,Möller Mandy‐Deborah¹²,Reinhardt Heike¹²^ORCID,Wäsch Ralph¹²,Engelhardt Monika¹²^ORCID

Affiliation:

1. Department of Medicine I: Hematology and Oncology Medical Center/Faculty of Medicine University of Freiburg Freiburg Germany

2. Comprehensive Cancer Center Freiburg Medical Center/Faculty of Medicine University of Freiburg Freiburg Germany

3. Clinical Trials Unit Medical Center/Faculty of Medicine University of Freiburg Freiburg Germany

Funder

Deutsche Krebshilfe

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33658

Reference46 articles.

1. A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients

2. Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores

3. Multiple myeloma: 2020 update on diagnosis, risk‐stratification and management

4. From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives

5. Melphalan 140 mg/m 2 or 200 mg/m 2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physical activity and exercise motivation of multiple myeloma patients: a prospective cross-sectional study;The Oncologist;2024-07-02

2. Original Paper Optimizing individualized therapy decision-making in multiple myeloma (MM): Integration and impact of the Revised Myeloma Comorbidity Index in the MM-Tumor Board;2024-06-10

3. Risk stratification in multiple myeloma – A review and update;Annals of the National Academy of Medical Sciences (India);2024-05-02

4. Daratumumab Treatment for “Truly Frail” Elderly Myeloma Patients;Life;2024-03-15

5. The Haemato‐Oncology Frailty (HOF) score to assess frailty in lymphoma;European Journal of Haematology;2023-12-19